Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Mallinckrodt
Colorcon
Deloitte
Chubb
US Army
AstraZeneca
UBS
Johnson and Johnson

Generated: November 19, 2018

DrugPatentWatch Database Preview

Siga Technologies Company Profile

« Back to Dashboard

What is the competitive landscape for SIGA TECHNOLOGIES, and when can generic versions of SIGA TECHNOLOGIES drugs launch?

SIGA TECHNOLOGIES has one approved drug.

There are six US patents protecting SIGA TECHNOLOGIES drugs.

Summary for Siga Technologies
US Patents:6
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Siga Technologies

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Siga Technologies TPOXX tecovirimat CAPSULE;ORAL 208627-001 Jul 13, 2018 RX Yes Yes 9,339,466 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Siga Technologies TPOXX tecovirimat CAPSULE;ORAL 208627-001 Jul 13, 2018 RX Yes Yes 8,802,714 ➤ Try a Free Trial ➤ Try a Free Trial
Siga Technologies TPOXX tecovirimat CAPSULE;ORAL 208627-001 Jul 13, 2018 RX Yes Yes 8,039,504 ➤ Try a Free Trial Y ➤ Try a Free Trial
Siga Technologies TPOXX tecovirimat CAPSULE;ORAL 208627-001 Jul 13, 2018 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Siga Technologies TPOXX tecovirimat CAPSULE;ORAL 208627-001 Jul 13, 2018 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Siga Technologies TPOXX tecovirimat CAPSULE;ORAL 208627-001 Jul 13, 2018 RX Yes Yes 8,530,509 ➤ Try a Free Trial Y ➤ Try a Free Trial
Siga Technologies TPOXX tecovirimat CAPSULE;ORAL 208627-001 Jul 13, 2018 RX Yes Yes 7,737,168 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Siga Technologies Drugs

Country Document Number Estimated Expiration
Canada 2793533 ➤ Try a Free Trial
European Patent Office 2148860 ➤ Try a Free Trial
South Korea 20160062208 ➤ Try a Free Trial
Canada 2866037 ➤ Try a Free Trial
Australia 2007351866 ➤ Try a Free Trial
Japan 2013522371 ➤ Try a Free Trial
Japan 2018012735 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Chinese Patent Office
Dow
Harvard Business School
Citi
Mallinckrodt
Federal Trade Commission
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.